Bio Protocol Prijs
BIORang 372
Bio Protocol (BIO) Prijs Live Grafiek
De prijs van Bio Protocol (BIO) is vandaag $0.03314, met een 24-uurs handelsvolume van $933.3K. Hierdoor heeft Bio Protocol (BIO) een marktkapitalisatie van $71.22M, wat neerkomt op een marktdominantie van 0.0041%. De prijs van Bio Protocol (BIO) is de afgelopen 24 uur met -7.02% veranderd.
BIO Prijsgegevens
- 24u Omzet$933.3K
- All Time High (ATH)$1.09
- 24u hoog$0.03753
- All-Time Low (ATL)$0.01568
- 24u Laag$0.03205
BIO Marktkapitalisatie-info
- Marktkapitalisatie$71.22M
- Volledig verwaterde waardering$110.02M
- Marktkapitalisatie/FDV64.74%
- MarktsentimentNeutraal
BIO Aanbod
- Circulerend aanbod2.14B BIO
- Totale voorraad3.32B BIO
- Maximale voorraad3.32B BIO
*Gegevens zijn alleen ter referentie
Bio Protocol(BIO) wordt voorspeld gemiddeld $0.03336 te zijn in 2026, met een mogelijke schommeling tussen de laagste prijs $0.02101 en de hoogste prijs $0.0457. Tegen 2031 kan de prijs van Bio Protocol(BIO) oplopen tot $0.08535, wat een potentieel rendement van +83.00% biedt ten opzichte van de huidige Bio Protocol-prijs.
Jaar | Minimale prijs | Hoogste prijs | Gemiddelde prijs | Verandering |
|---|---|---|---|---|
2026 | $0.02101 | $0.0457 | $0.03336 | -- |
2027 | $0.02806 | $0.04467 | $0.03953 | +19.00% |
2028 | $0.02357 | $0.05473 | $0.0421 | +27.00% |
2029 | $0.04696 | $0.06826 | $0.04841 | +46.00% |
2030 | $0.02975 | $0.06359 | $0.05834 | +76.00% |
2031 | $0.04206 | $0.08535 | $0.06096 | +83.00% |
De prijs van Bio Protocol(BIO) is de afgelopen 24 uur met -7.02% bewogen, en met +14.12% in de afgelopen 7 dagen. De prijs van Bio Protocol(BIO) is +99.52% in de afgelopen 30 dagen, en -56.76% over het afgelopen jaar.
Tijdsperiode | Bedrag wijzigen | % Verandering |
|---|---|---|
1H | -$0.0002 | -0.6% |
24H | -$0.002502 | -7.02% |
7D | +$0.0041 | +14.12% |
30D | +$0.01653 | +99.52% |
1Y | -$0.0435 | -56.76% |
Over Bio Protocol (BIO)
Contract
0xcb15925...767ee5ffa
Verkenners
etherscan.io
Website
bio.xyz
Community
BIO is a curation and liquidity protocol for Decentralized Science (DeSci). Their mission is to accelerate biotechnology by giving global communities of patients, scientists and biotech professionals the ability to collectively fund, build and own tokenized biotech projects and intellectual property (IP).
Bio Protocol (BIO) teamleden
Paul KohlhaasFounder
CEO
Clemens OrtleppCo-Founder
CPO
James SinkaCo-Founder
Science Lead
Tyler GolatoCo-Initiator
Bio Protocol (BIO) Investeerders
Binance Labs
Mechanism Capital
Mirana Ventures
Maelstrom
Foresight Ventures
Animoca Brands
Big Brain Holdings
Zee Prime Capital- GateNewsMicrosoft reported $82.9 billion in fiscal third-quarter revenue on Wednesday, beating Wall Street's estimate of $81.39 billion as Azure cloud services growth reached 40%. The company posted adjusted earnings per share of $4.27, above the $4.06 expected by analysts. Microsoft's AI business
- GateNewsOn April 29, the U.S. Dollar Index rose 0.32% to close at 98.956. The index measures the dollar's strength against six major currencies. EUR/USD fell to 1.1682 from 1.1714, while GBP/USD declined to 1.3483 from 1.3518. USD/JPY rose to 160.32 from 159.55, and USD/CHF strengthened to 0.7907 from 0.789
- GateNewsAccording to Gate market data, U.S. stock indices closed mixed on Wednesday, April 29. The Dow Jones Industrial Average fell 0.57%, the S&P 500 declined 0.04%, while the Nasdaq Composite rose 0.04%. NXP Semiconductors surged 25%, Intel gained 12%, and Qualcomm rose 4%, while Nvidia fell 1.8%. The Na
- GateNewsAccording to the Wall Street Journal and CME futures data, traders are now pricing in an 11% probability of a Federal Reserve rate hike this year, up from 0% on Tuesday and 5% earlier on April 29. The shift follows hawkish signals from Fed officials. Meanwhile, the probability of a rate cut stands a
- GateNewsOn Wednesday, Dogecoin crossed $0.10 for the first time in two months, with 24-hour trading volume surging 138% to $4.07 billion. Crypto analyst Ali Martinez identified $0.1018 as a critical resistance level and projects the next price target near $0.1172. Asset manager 21Shares listed a
- $BIO Rejected at resistance. No follow-through. SHORT $BIO Entry: 0.0320 – 0.0325 SL: 0.0350 TP1: 0.0305 TP2: 0.0290 TP3: 0.0275 Lower high forming. Red volume picking up. Supply zone rejecting. Bulls getting exhausted. Most will wait for a bounce. I'm already short. DilbaTheGreatBIO-6.68%
BIO is currently pushing into a key resistance zone around 0.034–0.035 after a strong impulsive move from the lows. The sharp rally shows clear buyer strength, but price is now reacting at a level that has previously acted as supply. This area is critical. If BIO fails toBossMdBIO-6.68%- $BIO is currently at $0.0331. Price is seeing a pullback after a failed breakout attempt, with a series of lower highs suggesting a short-term struggle for momentum. Support to watch: $0.0275 – $0.0290. Resistance to watch: $0.0385 – $0.0405. #BIO #Crypto #TradingGateUser-ffecf12bBIO-6.68%
- Only a few are positioned before TL wakes up. $BIO @BioProtocol @peptai_ $FOLD @clarity_proto $PEPTIDE @Peptiderx_ $PEPT @peptome_aiGateUser-79eee386BIO-6.68%
- Again Risking my portfolio shorting $BIO {future}(BIOUSDT)CryptoManMabBIO-6.68%
- $BIO Trade Setup: Long Entry Zone: 0.0348 – 0.0358 TP1: 0.0370 TP2: 0.0388 TP3: 0.0405 SL: 0.0335 #WCTCTradingKingPKBit_RiseBIO-6.68%
